论文部分内容阅读
目的:对慢性阻塞性肺疾病(COPD)合并Ⅱ型呼吸衰竭应用双水平无创正压通气疗法的临床效果和有效性进行探究展。方法:在2014年6月到2016年6月这两年时间中,我院共收治COPD合并Ⅱ型呼吸衰竭患者138例,选取自愿参与研究的62例患者作为研究对象。将这62例患者随机平均分成A组和B组,A、B两组均实行常规治疗,A组额外增加双水平无创正压通气治疗,对二者的临床效果和恢复情况进行比较。结果:治疗后A组患者有显著效果的有27例,有效率87.1%,B组患者有明显疗效的有18例,有效性58.1%。治疗A组的动脉血气分析也明显优于B组,二者的差异有统计学意义,(P<0.01)。结论:双水平无创正压通气治疗法在治疗COPD合并Ⅱ型呼吸衰竭疾病上有着明显的临床效果,能够缩短患者的康复时间,降低患者的痛苦,有很高的临床应用价值。
OBJECTIVE: To explore the clinical efficacy and effectiveness of bi-level noninvasive positive pressure ventilation in patients with chronic obstructive pulmonary disease (COPD) and type 2 respiratory failure. Methods: Between June 2014 and June 2016, 138 patients with COPD and type Ⅱ respiratory failure were enrolled in our hospital. Totally 62 patients who volunteered to participate in the study were selected as the study subjects. The 62 patients were randomly divided into A group and B group. A and B groups were treated routinely. A group was additionally treated with double-level noninvasive positive pressure ventilation. The clinical effect and recovery of the two groups were compared. Results: After treatment, there were 27 cases with significant effect in group A, the effective rate was 87.1%. In group B, there were 18 cases with obvious curative effect and the effectiveness was 58.1%. Arterial blood gas analysis in treatment group A was also superior to that in group B, the difference was statistically significant (P <0.01). Conclusion: The bi-level noninvasive positive pressure ventilation has significant clinical effect in the treatment of COPD with type Ⅱ respiratory failure. It can shorten the recovery time of patients and reduce the suffering of patients with high clinical value.